Internal Medicine · Pocatello, ID
NPI
1225061351
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2302 E. Terry Street
Pocatello, ID, 83201
Phone (208) 235-5910
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
308 services
Medicare patients, 2024
207
Average age 71
Drug cost, 2024
$1.8M
4,303 prescriptions
Company payments, 2025
$136K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sherwin D'Souza was code 99213 (office e&m - established), 141 times for 127 patients. In total Sherwin D'Souza billed 308 services in 12 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 141 | 127 | $42.41 | $5,980 |
| 99214 Office E&M - Established | Office | 59 | 52 | $58.90 | $3,475 |
| 95251 Test - Miscellaneous | Office | 49 | 35 | $21.39 | $1,048 |
| 99204 Office E&M - New | Office | 21 | 21 | $77.84 | $1,635 |
| 99212 Office E&M - Established | Office | 12 | 12 | $21.55 | $259 |
| 99205 Office E&M - New | Office | 11 | 11 | $71.47 | $786 |
By year: 2022 $16K for 369 services; 2023 $14K for 310 services; 2024 $14K for 308 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sherwin D'Souza prescribed most often to Medicare patients was Repatha Sureclick (Evolocumab), with 513 prescriptions and refills. In total Sherwin D'Souza wrote 4,303 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Repatha Sureclick Evolocumab | 513 | 814 | 120 | $460K |
| Ezetimibe Generic | 404 | 1,060 | 162 | $6,767 |
| Levothyroxine Sodium Generic | 320 | 891 | 86 | $4,045 |
| Rosuvastatin Calcium Generic | 317 | 830 | 117 | $3,586 |
| Ozempic Semaglutide | 161 | 230 | 29 | $204K |
| Atorvastatin Calcium Generic | 141 | 332 | 47 | $1,178 |
| Metformin Hcl Er Metformin Hcl | 114 | 307 | 37 | $1,656 |
| Vascepa Icosapent Ethyl | 84 | 209 | 35 | $70K |
| Methimazole Generic | 78 | 180 | 22 | $635 |
| Jardiance Empagliflozin | 78 | 156 | 21 | $88K |
| Nexletol Bempedoic Acid | 76 | 192 | 32 | $75K |
| Praluent Pen Alirocumab | 72 | 121 | 20 | $59K |
| Mounjaro Tirzepatide | 72 | 81 | 16 | $83K |
| Metformin Hcl Generic | 64 | 192 | 23 | $622 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 63 | 153 | 23 | $7,901 |
Brand drugs: 1,883 claims; generic drugs: 2,228 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sherwin D'Souza $136K ($136K in general payments such as food, travel and fees) from 17 companies. The largest payer was Lilly USA, LLC with $43K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 55 | $43K |
| Madrigal Pharmaceuticals MDGL | 41 | $28K |
| Novo Nordisk Inc NVO | 21 | $24K |
| Eli Lilly and Company LLY | 14 | $17K |
| Novo Nordisk AS NVO | 6 | $15K |
| Amgen Inc. AMGN | 10 | $7,476 |
| Insulet Corporation PODD | 4 | $242 |
| Ascendis Pharma Endocrinology Inc ASND | 7 | $186 |
| Medtronic, Inc. MDT | 1 | $184 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $160 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.